222 related articles for article (PubMed ID: 22555266)
1. Comparison of cardiac resynchronization therapy outcomes in patients with New York Heart Association functional class I/II versus III/IV heart failure.
Bank AJ; Rischall A; Gage RM; Burns KV; Kubo SH
J Card Fail; 2012 May; 18(5):373-8. PubMed ID: 22555266
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Extrapolation of Clinical Benefits Among Patients With Mild Heart Failure Receiving Cardiac Resynchronization Therapy: Analysis of the 5-Year Follow-Up From the REVERSE Study.
Gold MR; Padhiar A; Mealing S; Sidhu MK; Tsintzos SI; Abraham WT
JACC Heart Fail; 2015 Sep; 3(9):691-700. PubMed ID: 26277764
[TBL] [Abstract][Full Text] [Related]
3. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C;
Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006
[TBL] [Abstract][Full Text] [Related]
4. Long-term outcomes in patients with ambulatory new york heart association class III and IV heart failure undergoing cardiac resynchronization therapy.
Rickard J; Bassiouny M; Tedford RJ; Baranowski B; Spragg D; Cantillon D; Varma N; Wilkoff BL; Tang WH
Am J Cardiol; 2015 Jan; 115(1):82-5. PubMed ID: 25491007
[TBL] [Abstract][Full Text] [Related]
5. Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure.
Linde C; Daubert C; Abraham WT; St John Sutton M; Ghio S; Hassager C; Herre JM; Bergemann TL; Gold MR;
Circ Heart Fail; 2013 Nov; 6(6):1180-9. PubMed ID: 24014828
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry).
Landolina M; Lunati M; Gasparini M; Santini M; Padeletti L; Achilli A; Bianchi S; Laurenzi F; Curnis A; Vincenti A; Valsecchi S; Denaro A;
Am J Cardiol; 2007 Sep; 100(6):1007-12. PubMed ID: 17826388
[TBL] [Abstract][Full Text] [Related]
7. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms.
Linde C; Abraham WT; Gold MR; St John Sutton M; Ghio S; Daubert C;
J Am Coll Cardiol; 2008 Dec; 52(23):1834-1843. PubMed ID: 19038680
[TBL] [Abstract][Full Text] [Related]
8. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
Bleeker GB; Schalij MJ; Holman ER; Steendijk P; van der Wall EE; Bax JJ
Am J Cardiol; 2006 Jul; 98(2):230-5. PubMed ID: 16828599
[TBL] [Abstract][Full Text] [Related]
9. Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association class I/II heart failure.
St John Sutton M; Ghio S; Plappert T; Tavazzi L; Scelsi L; Daubert C; Abraham WT; Gold MR; Hassager C; Herre JM; Linde C;
Circulation; 2009 Nov; 120(19):1858-65. PubMed ID: 19858419
[TBL] [Abstract][Full Text] [Related]
10. Left Ventricular Architecture, Long-Term Reverse Remodeling, and Clinical Outcome in Mild Heart Failure With Cardiac Resynchronization: Results From the REVERSE Trial.
St John Sutton M; Linde C; Gold MR; Abraham WT; Ghio S; Cerkvenik J; Daubert JC;
JACC Heart Fail; 2017 Mar; 5(3):169-178. PubMed ID: 28254122
[TBL] [Abstract][Full Text] [Related]
11. Echocardiographic phase imaging to predict reverse remodeling after cardiac resynchronization therapy.
Buss SJ; Humpert PM; Bekeredjian R; Hardt SE; Zugck C; Schellberg D; Bauer A; Filusch A; Kuecherer H; Katus HA; Korosoglou G
JACC Cardiovasc Imaging; 2009 May; 2(5):535-43. PubMed ID: 19442937
[TBL] [Abstract][Full Text] [Related]
12. Acute effects of withdrawal of cardiac resynchronization therapy on left and right ventricular function, dyssynchrony, and contractile function in patients with New York Heart Association functional class I/II heart failure: MADIT-CRT.
Knappe D; Pouleur AC; Shah AM; Bourgoun M; Brown MW; Foster E; Pfeffer MA; Moss AJ; Solomon SD;
J Card Fail; 2013 Mar; 19(3):149-55. PubMed ID: 23482074
[TBL] [Abstract][Full Text] [Related]
13. Effect of cardiac resynchronization therapy in patients with New York Heart Association functional class IV heart failure.
van Bommel RJ; van Rijnsoever E; Borleffs CJ; Delgado V; Marsan NA; Bertini M; Schalij MJ; Bax JJ
Am J Cardiol; 2010 Oct; 106(8):1146-51. PubMed ID: 20920655
[TBL] [Abstract][Full Text] [Related]
14. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial.
Khan FZ; Virdee MS; Palmer CR; Pugh PJ; O'Halloran D; Elsik M; Read PA; Begley D; Fynn SP; Dutka DP
J Am Coll Cardiol; 2012 Apr; 59(17):1509-18. PubMed ID: 22405632
[TBL] [Abstract][Full Text] [Related]
15. Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography.
Yu CM; Chan YS; Zhang Q; Yip GW; Chan CK; Kum LC; Wu L; Lee AP; Lam YY; Fung JW
J Am Coll Cardiol; 2006 Dec; 48(11):2251-7. PubMed ID: 17161255
[TBL] [Abstract][Full Text] [Related]
16. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
[TBL] [Abstract][Full Text] [Related]
17. E/A ratio before cardiac resynchronization therapy predicts left ventricle reverse remodeling.
Iori M; Bottoni N; Quartieri F; Manari A
Minerva Cardioangiol; 2014 Aug; 62(4):305-9. PubMed ID: 25012099
[TBL] [Abstract][Full Text] [Related]
18. Cardiac resynchronization therapy in patients with mild heart failure: a systematic review and meta-analysis.
Santangeli P; Di Biase L; Pelargonio G; Dello Russo A; Casella M; Bartoletti S; Burkhardt JD; Mohanty P; Santarelli P; Natale A
J Interv Card Electrophysiol; 2011 Nov; 32(2):125-35. PubMed ID: 21594629
[TBL] [Abstract][Full Text] [Related]
19. A randomized double-blind comparison of biventricular versus left ventricular stimulation for cardiac resynchronization therapy: the Biventricular versus Left Univentricular Pacing with ICD Back-up in Heart Failure Patients (B-LEFT HF) trial.
Boriani G; Kranig W; Donal E; Calo L; Casella M; Delarche N; Lozano IF; Ansalone G; Biffi M; Boulogne E; Leclercq C;
Am Heart J; 2010 Jun; 159(6):1052-1058.e1. PubMed ID: 20569719
[TBL] [Abstract][Full Text] [Related]
20. Interplay between right ventricular function and cardiac resynchronization therapy: an analysis of the CARE-HF trial (Cardiac Resynchronization-Heart Failure).
Damy T; Ghio S; Rigby AS; Hittinger L; Jacobs S; Leyva F; Delgado JF; Daubert JC; Gras D; Tavazzi L; Cleland JG
J Am Coll Cardiol; 2013 May; 61(21):2153-60. PubMed ID: 23541971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
